{
  "id": "hydroxychloroquine_dosing",
  "title": "Hydroxychloroquine (Plaquenil) Dosing Calculator",
  "description": "Calculates maximum daily hydroxychloroquine dose to reduce retinopathy risk. Uses actual body weight to determine safe dosing limits based on 2016 American Academy of Ophthalmology guidelines recommending ≤5 mg/kg/day to minimize retinal toxicity.",
  "category": "rheumatology",
  "version": "2016",
  "parameters": [
    {
      "name": "weight_kg",
      "type": "float",
      "required": true,
      "description": "Patient's actual body weight in kilograms",
      "unit": "kg",
      "validation": {
        "min": 20,
        "max": 300
      }
    },
    {
      "name": "indication",
      "type": "string",
      "required": true,
      "description": "Clinical indication for hydroxychloroquine therapy",
      "options": [
        "rheumatoid_arthritis",
        "systemic_lupus_erythematosus",
        "malaria_prophylaxis",
        "malaria_treatment",
        "other_autoimmune"
      ],
      "validation": {
        "enum": [
          "rheumatoid_arthritis",
          "systemic_lupus_erythematosus", 
          "malaria_prophylaxis",
          "malaria_treatment",
          "other_autoimmune"
        ]
      }
    },
    {
      "name": "risk_factors",
      "type": "string",
      "required": true,
      "description": "Presence of risk factors for retinopathy (age >65, renal disease, liver disease, previous retinal disease)",
      "options": ["none", "one_or_more"],
      "validation": {
        "enum": ["none", "one_or_more"]
      }
    }
  ],
  "result": {
    "name": "max_daily_dose",
    "type": "float",
    "unit": "mg",
    "description": "Maximum recommended daily dose of hydroxychloroquine"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 200,
        "stage": "Low Dose",
        "description": "≤200 mg daily",
        "interpretation": "Very low risk of retinopathy. Suitable for patients with multiple risk factors or lower weight. Regular ophthalmologic screening still recommended per guidelines."
      },
      {
        "min": 201,
        "max": 400,
        "stage": "Standard Dose",
        "description": "201-400 mg daily",
        "interpretation": "Standard therapeutic dose with low retinopathy risk when ≤5 mg/kg actual weight. Appropriate for most patients with rheumatoid arthritis or lupus. Annual eye exams recommended after 5 years of use."
      },
      {
        "min": 401,
        "max": 600,
        "stage": "High Dose",
        "description": ">400 mg daily",
        "interpretation": "Higher dose requiring careful monitoring. Ensure dose remains ≤5 mg/kg actual weight. Consider dose reduction if possible while maintaining therapeutic efficacy. More frequent ophthalmologic monitoring may be indicated."
      }
    ]
  },  
  "references": [
    "Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016 Jun;123(6):1386-94.",
    "Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453-60.",
    "Jorge AM, Melles RB, Zhang Y, Lu N, Rai SK, Young LH, Choi HK. Hydroxychloroquine retinopathy--implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018 Dec;14(12):693-703."
  ],
  "formula": "Maximum daily dose (mg) = actual body weight (kg) × 5 mg/kg. Consider dose reduction if risk factors present or for long-term use (>5 years).",
  "notes": [
    "2016 AAO guidelines reduced maximum dose from 6.5 mg/kg to 5 mg/kg based on retinopathy evidence",
    "Actual body weight preferred over ideal body weight for dose calculation",
    "Doses >5 mg/kg actual weight significantly increase retinopathy risk",
    "10-year retinopathy risk: 2% (≤5 mg/kg) vs 10% (>5 mg/kg)",
    "20-year retinopathy risk: 20% (≤5 mg/kg) vs 40% (>5 mg/kg)",
    "Risk factors: age >65, renal disease, liver disease, previous retinal disease",
    "Baseline ophthalmologic exam recommended before starting therapy",
    "Annual screening recommended after 5 years of use (earlier if risk factors)",
    "Consider dose reduction for patients with risk factors even if within weight limits",
    "Cumulative dose and duration of therapy also contribute to retinopathy risk",
    "Retinopathy may progress even after drug discontinuation"
  ]
}